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Abstract
Background: Laboratory conditions nullify the extrinsic factors that determine the wild expected lifespan and release the
intrinsic or potential lifespan. Thus, wild animals reared in a laboratory often show an increased lifespan, and consequently
an increased senescence phase. Senescence is associated with a broad suite of physiological changes, including a decreased
responsiveness of the circadian system. The time-keeping hormone melatonin, an important chemical player in this system,
is suspected to have an anti-aging role. The Greater White-toothed shrew Crocidura russula is an ideal study model to
address questions related to aging and associated changes in biological functions: its lifespan is short and is substantially
increased in captivity; daily and seasonal rhythms, while very marked the first year of life, are dramatically altered during the
senescence process which starts during the second year. Here we report on an investigation of the effects of melatonin
administration on locomotor activity of aging shrews.
Methodology/Principal Findings: 1) The diel fluctuations of melatonin levels in young, adult and aging shrews were
quantified in the pineal gland and plasma. In both, a marked diel rhythm (low diurnal concentration; high nocturnal
concentration) was present in young animals but then decreased in adults, and, as a result of a loss in the nocturnal
production, was absent in old animals. 2) Daily locomotor activity rhythm was monitored in pre-senescent animals that had
received either a subcutaneous melatonin implant, an empty implant or no implant at all. In non-implanted and sham-
implanted shrews, the rhythm was well marked in adults. A marked degradation in both period and amplitude, however,
started after the age of 14–16 months. This pattern was considerably delayed in melatonin-implanted shrews who
maintained the daily rhythm for significantly longer.
Conclusions: This is the first long term study (.500 days observation of the same individuals) that investigates the effects of
continuous melatonin delivery. As such, it sheds new light on the putative anti-aging role of melatonin by demonstrating
that continuous melatonin administration delays the onset of senescence. In addition, the shrew appears to be a promising
mammalian model for elucidating the precise relationships between melatonin and aging.
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Introduction
Senescence is defined as the increase in the rate of mortality and
the decrease of reproductive success as a function of age [1,2]. This
phenomenon is the result of a complex combination of
physiological changes that occur at the level of the whole organism
as well as individual organs and tissues [3]. In mammals, these
changes lead to a decreased responsiveness to the phase-shifting
effects of light stimuli which is characterized by an alteration of the
sleep/wake pattern and a decrease in daytime alertness and
cognitive performance. Although little is known about the precise
physiological mechanisms underlying normal age-related changes
in biological timing, it has been suggested that they reflect changes
in the suprachiasmatic nucleus (SCN), the neural structure thought
to be primarily responsible for generation of the circadian
oscillation [4]. The SCN of the hypothalamus constitutes the
master circadian pacemaker whose activity is synchronized by the
photoperiodic information perceived through the eyes. One SCN
output pathway ends at the pineal gland and induces the rhythmic
(nocturnal) production of melatonin [5]. The time-keeping
properties of melatonin result in part from feed-back action on
the SCN. Melatonin production decays during aging (reviewed in
[6,7]). Pinealectomy leads to an acceleration of many aspects of
the aging process which can be partially reversed or reduced by
melatonin treatment [8–10]. This set of clues indicates that the
hormone might play an anti-aging role [11]. Until now, studies
aimed at understanding the specific effects of melatonin on age-
related deterioration of the circadian rhythm were based on short-
term acute melatonin administration [12–14]. As a result, it
remains unclear if the anti-aging effect of melatonin on the time-
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production per se.
As in all shrews, Greater White-toothed shrew Crocidura russula
(Hermann, 1780) physiology is notable for extremely rapid gas
exchange. Its mass-specific metabolic rate is among the highest
ever measured in terrestrial mammals [15–19]. As predicted by
the rate-of-living theory [20] (the higher the energy expenditure,
the shorter the lifespan), C. russula’s lifespan is only 18 months in
the wild [21] but it can be increased up to 30 months under
laboratory conditions [22]. C. russula exhibits seasonal and daily
rhythmic components in most of its biological functions including
reproduction, thermoregulation, coat replacement and locomotor
activity [19]. Shrews maintain their daily and seasonal rhythms up
to one year after weaning. At that point, senesence related
processes such as arrhythmic daily locomotor activity, absence of
reproduction and erratic shedding begin to appear [23]. Despite
the increased lifespan under laboratory conditions, the aging
process in captive animals starts at the same point as in wild
animals. Because of its extreme metabolic rate, its pronounced
biorhythmicity and its short lifespan, C. russula is an ideal study
model to investigate the possible effects of melatonin on the
deterioration of biorhythms due to senescence.
To determine whether it is the rhythmic administration of
melatonin or the administration itself that impacts traits related to
aging, we investigated the effect of a long-term continuous
melatonin delivery on adults C. russula. We monitored the daily
activity rhythms of animals starting just before the first clues of
senescence appeared until death, i.e., over a period of more than
500 days. To the best of our knowledge, this is the first time that
such a long-term survey has been performed. We show that a
continuous delivery of melatonin through subcutaneous implants,
maintains the rhythmic activity pattern in aging animals for an
additional year when compared to controls.
Results
Melatonin measurements
Pineal gland and plasma melatonin concentrations. A
similar pattern of melatonin production was observed in the pineal
gland and plasma (sample size of respectively 31 and 44) (Fig. 1).
Night-time melatonin concentrations decreased significantly with
age, whereas daytime levels were not affected and remained low
lifelong. A daily pattern was evident for only up to 12 month old
(mo) shrews (Fig. 1), although nocturnal levels were lower in adult
(6–12 mo) vs. young (,6 mo) shrews. In aged (.12 mo) shrews,
nocturnal melatonin levels were similar to diurnal levels both in
the pineal gland and plasma.
Melatonin release by the implant. Melatonin
measurements were made in four implanted shrews in order to
estimate the levels induced by the implant. Plasma levels averaged
50 ng/ml one week after implantation (2 animals), and decreased
to 120 pg/ml 3 months later (2 animals). In the in vitro system,
melatonin release diminished with time, fitting an exponential
decay (Fig. 2). High at the beginning of the experiment, it
decreased rapidly during the first ten days and then remained
within the same order of magnitude until the end of the survey.
Diel locomotor activity rhythm
All individuals, aged 11–15 mo, displayed a marked diel activity
rhythm, which was the highest during the first half of the night
(expressed as the number of nest exits per hour) (Fig. 3). A
secondary smaller peak was observed early during the light phase
(Fig. 3). This bimodal pattern had a marked 24 h periodicity of
high amplitude. After month 15, the amplitude of the rhythm
decreased dramatically in both controls and sham-implanted
shrews, and was no longer observed after month 17 (Figs 3, 4). In
parallel, the significance of the 24 h period also decreased to the
point where it was no longer discernable (Figs 3, 4). In contrast, in
the implanted animals (i) the first noticeable decrease in amplitude
of the rhythm was delayed by 3 months and (ii) the 24 h period
remained highly significant until death (Figs 3, 4). In addition, the
second and, to a lesser extent, the third implants induced a
temporary gain in amplitude (Fig. 4B).
Discussion
This study provides new and important data on the role of
melatonin in both the regulation of clock-controlled processes and
aging. The continuous monitoring of spontaneous locomotor
activity has emerged as one of the most widely used behavioral
outputs in circadian research. More specifically, it is considered as
extremely useful for the description of the effects of aging on
circadian rhythms [24]. Here we report on the first long term (.2
years) investigation of the effects of a continuous melatonin
treatment on the behavior of a vertebrate.
Age-related disruption of the melatonin rhythm
This is the first set of experiments aimed at characterizing the
diel pattern of melatonin secretion in the shrew. Two main
characteristics were found. First, in untreated animals, pineal
gland and plasma variations in melatonin content were strongly
correlated. Second, in agreement with studies of other vertebrates
[25,26], both profiles changed dramatically during the course of
the shrews’ life. The diel rhythm was robust in young animals
(,7 mo), diminished in adults (7–12 mo), and absent in aged
shrews .12 mo). This resulted from a progressive decrease in the
nocturnal production. These data fit with the known biology of the
C. russula and its lifespan which is only 18 months in the wild [21].
It is a well known phenomenon that aging results in decreased
nocturnal melatonin production and deterioration of the daily
rhythmic pattern [7,27–31]. The reasons are yet unknown, and
may involve a disruption at some step of the circadian pathway
that controls the nocturnal surge in melatonin secretion [32].
Degenerative changes are observed in the optic nerve and retina of
aging humans [33]. Aging may impair the sensitivity of the SCN to
retinal input [9,30]. A compelling set of studies also reports a
deterioration within the clock mechanism of the SCN itself
[7,9,30,34]. Finally, it is possible that the decline in melatonin
production with age is a consequence of a deficit at the level of the
pineal gland. As suggested elsewhere [6], reduced activity of the
arylalkylamine N-acetyltransferase, linked to an impaired pineal
catecholaminergic neurotransmission, could result in diminished
or suppressed nocturnal production. Moreover, the aging process
leads to pineal gland calcification [35,36]. Our investigations
(unpublished) have shown modifications at the level of the
pinealocytes and an accumulation of calcium deposits in both
the pineal organ and retina of aged shrews compared to young
individuals. Altogether, these data indicate that shrews older than
12 months have entered the aging process. This conclusion is
supported by our studies on the locomotor activity, as discussed
below.
Age-related disruption of locomotor activity rhythm
Adult shrews (12 mo) exhibited a significant bimodal diel
pattern of activity of marked amplitude. We found that the
amplitude of the rhythm decreased dramatically in controls and
sham-implanted shrews, starting the second year of life, such that
no rhythm was apparent after month 17. This is consistent with
Melatonin Delays Senescence
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was parallel to the decrease of pineal gland and plasma melatonin
levels described above. Whether there is a causal relationship
between the age-related loss in melatonin production and the
response to photoperiod [7] remains an open issue. It is interesting
to note that the melatonin rhythm does disappear in healthy old
men, except centenarians [31,38]. Understanding what factors
underlie the disruption of the circadian system, including
melatonin production, remains an issue of considerable interest
[24,34]. In this regard, the continuous monitoring, over more than
500 days, of the spontaneous locomotor activity of C. russula, turns
out to be extremely useful for the characterization of the effects of
aging on daily rhythms. This unique system provides original and
interesting data on the effects of melatonin on the age-related loss
of locomotor activity rhythm.
Melatonin treatment and locomotor activity rhythm
Insertion of a subcutaneous melatonin implant induced a
dramatic increase in plasma melatonin level in shrews where it was
measured. At one week and three months after implantation,
plasma melatonin levels were <5000-fold and 20-fold, respectively
the nocturnal levels of control shrews. Assuming a half life of
<20 min for plasma melatonin [39], it seems that the values found
in the in vitro system (as expressed per day in Fig. 2) are within the
range of those measured in the plasma of the implanted animals.
This would indicate that there was an extremely high release over
Figure 1. Day/night variations in pineal and plasma melatonin in shrews from different ages. Shrews were grouped as young (,7 mo),
adult (7–12 mo) and aged (.12 mo) as indicated on the abscissa. Values are expressed as the mean6Standard Error of the Mean (SEM). The number
of individuals is indicated below the corresponding column. There was a significant effect of age on both pineal gland and plasma melatonin content
(SRH test: P=0.001 and P=0.003 respectively). Pineal gland and plasma concentrations of young and adult animals were significantly different
between night and day, but this marked diel rhythm disappeared in old animals as a result of a loss in the nocturnal production (different letters
indicate significant differences, Mann-Whitney U test, P,0.05).
doi:10.1371/journal.pone.0005904.g001
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nevertheless remained high compared to melatonin concentrations
quantified in the plasma of non-implanted animals. It is therefore
clear that we are dealing here with pharmacological levels
delivered on a continuous basis.
Previous studies had tested the effects of melatonin on age-
related decreases in daily activity rhythms. However, these were
short-term studies that delivered melatonin on an acute or chronic
basis [12–14]. The present study emphasizes that a treatment
delivering high doses of melatonin continuously does not suppress
the diel activity pattern in adult shrews. On the contrary, the
rhythm of 12 mo individuals was reinforced. Furthermore, the
long-term treatment slowed the age-induced loss of shrew
rhythmic behavior. It is notable that melatonin does not need to
be delivered on a rhythmic basis in order to allow maintaining the
synchronization of the daily activity pattern. This suggests that
constant delivery of the hormone, when provided before the onset
of senesence, compensates for the lack of production by aged
animals. As discussed above for melatonin, the degradation of the
daily rhythm in the aging shrew probably reflects changes in the
circadian system that controls it. Alterations are likely to affect the
pacemaker mechanism itself [40]. It is possible that the effects of
melatonin observed here are due to a protective action on the
SCN, perhaps by taking over the natural production that normally
decreases with age. It has been suggested though that not all clock
stimuli lose their effectiveness with age and that it may be possible
to compensate for deficits in clock performance by enhancing the
strength of those stimulus pathways which are still intact [40]. A
recent model of the circadian clock suggests that outputs of the
clock which also feed back into it, can strengthen rhythms.
Melatonin could well be one of these enhancers because it is an
output of the circadian timing system that can also influence the
activity of SCN neurons [41]. Such clock-driven entraining agents
not only prevent rhythms from damping out in constant
conditions, but may also tune the phase sensitivity of the circadian
system. Melatonin increases the responsiveness of the circadian
system through the activation of its receptors in the SCN [9]; it is
also known that melatonin alters the firing rate of SCN neurons
and speeds entrainment to a change in the Light/Dark cycle. In
agreement with this idea, we observed that the shrews’ rhythmic
activity was reinforced each time a new implant was provided.
Conversely, implanting aged animals that had lost rhythmic
activity was ineffective (not shown). This would indicate that once
disorganized, locomotor activity rhythm cannot be rescued;
melatonin only serves to maintain an existing rhythm.
Daily rhythm, Senescence, and natural selection
The short lifespan of C. russula (an average of 18 months in the
wild [21]) is dramatically increased in captivity, where it frequently
reaches 30 months. Laboratory conditions remove most of the
extrinsic risks of mortality to which animals are exposed in the
wild, and allows observation of their potential (intrinsic) lifespan
[3]. With the exception of lifespan, all the major life-history traits
keep the same timing for captive shrews compared to wild ones.
Up to 12–14 mo, adult C. russula exhibit daily and seasonal
rhythms in most of their biological functions [42,43]. The first
signs of aging appear at the same time in laboratory conditions as
they do in the wild (arrhythmic daily locomotor activity and
thermoregulation, absence of reproduction and erratic shedding
[23]). Consequently, the adult phase remains the same in both
situations, whereas the senescence period is increased in captivity.
This result supports the disposable soma hypothesis [44]; the levels
of the extrinsic rates of mortality drive the patterns of protection
and repair mechanisms and may ultimately define lifespan. Hence,
if shrews live in a wild environment where a specific set of
constraints (resource availability, predation, parasitism) bring the
expectation of living beyond 18 mo to zero, the development of a
costly repair and protection mechanism that would keep the
animal alive for much longer cannot be favored by natural
selection. In captivity, even if animals are released from their
natural environment, they will show protection from oxidative
damage only for the ‘‘expected lifespan’’ (14–18 months) [3]. The
Figure 2. 24 h Melatonin release by the implant. Melatonin implants were individually immersed in 1 mL physiological buffer renewed every
24 hours for up to 130 days. Melatonin concentration measured in the physiological serum are the Mean6SEM (n is indicated under brackets). The
data fitted an exponential decay.
doi:10.1371/journal.pone.0005904.g002
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PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e5904Figure 3. Shrews’ locomotor activity over the duration of the experiment. A: Actograms of a control and a melatonin-implanted shrew
from the age of 12 to 30 months. Each line corresponds to one experimental day and there are 24 boxes per line (one box per hour). Nest exits are
expressed as a grey scale: the darker the area, the higher the activity for a particular period. Blue arrows indicate each time a new implant was
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correlation exists between the rate of metabolism and oxidative
damage, and supports the rate-of-living theory (the higher the
energy expenditure, the shorter the lifespan) [20,45]. Our
continuous melatonin treatment obviously slowed the rate of
aging of the diel locomotor activity rhythm. It is possible that the
effect of melatonin reported in the present work results from the
free radical scavenging properties of the hormone and its
metabolites, which is referred as the free radical scavenging
cascade [46]. Previous studies support evidence that aging is
Figure 4. Period and amplitude degradation indexes over the duration of the experiment. For each individual, the 24 h period (A) and
amplitude (B) degradation indexes were calculated as explained in the text, and are reported as a function of the time course of the experiment. The
blue arrows indicate each time a new implant was supplied. Values were calculated from the data presented in Figure 3.
doi:10.1371/journal.pone.0005904.g004
supplied. B: Daily activity profiles (mean6SEM) of controls (red) and melatonin-implanted (blue) shrews at, respectively, 12, 17, 21 and 30 months
after the beginning of the experiment. Shrews were submitted to a natural light–dark regime. Grey boxes correspond to the night. Due to mortality,
the number of individuals decreased during the experiment so that n was 11, 9, 6 and 4 at respectively month 12, 17, 21, and 30.
doi:10.1371/journal.pone.0005904.g003
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inflammation. In B6C3F1 mice, melatonin treatment restores a
more youthful gene profile in aged animals’ brains which, to a
large extent involves reversal of age-induced elevation of basal
inflammatory parameters [47]. Melatonin also counteracts the
age-related production of cytokines and nitric oxide in senescence-
accelerated mice [48]. Moreover, many tissues of old rats that
were pinealectomized at an early age (which induces melatonin
deficiency) show excessive oxidative damage compared to intact
animals [49].
The physiological changes that aging shrews undergo in the wild
are inimical to their survival. By decreasing body temperature and
slowing down heart and respiratory movements, along with some
other fundamental physiological functions, torpor allows adult
healthy shrews to reduce their energy expenditure during daylight
hours [50]. As circadian rhythms begin to dephase in aging animals,
they lose the ability to enter torpor and thus increase daily energy
expenditure. Moreover, being more active during the day exposes
wild senescent shrews to a higher probability of predation, thus
enhancing another component of the extrinsic mortality risk. And
yet, we hypothesize that the negative effects caused by age-related
behavioral disorders do not affect shrews’ fitness: the loss of diel
activity rhythms is concomitant with the loss of reproductive activity
(Fons, 1988). Once the reproductive potential of an individual is
over, one canassume that the maintenance of a coherent behavioral
rhythm is no longer under selection.
Conclusions
Shrews maintained in captivity exhibit a longer senescent phase
by switching from the expected lifespan (which is determined by
extrinsic factors in the wild) to an intrinsic or potential lifespan.
Moreover, thanks to their unique physiology, shrews provide a
portal through which we can discern the possible role of melatonin
in aging: the hormone alone, under continuous administration,
delays the appearance of one aspect of senescence, the loss of daily
activity rhythm. The mechanisms of melatonin action in the
implanted shrews and the physiological significance of our findings
are among the crucial questions that remain to be answered.
Melatonin could be acting either through receptor-based mech-
anisms [14] or by virtue of its antioxidant properties [11]. These
results are of primary interest for understanding the effects
melatonin has on the circadian system as well as on other processes




Wild White-toothed shrews C. russula were collected in the
Banyuls-sur-Mer area (Pyrene ´es-Orientales, France) using non-
baited pitfall traps. All the animals were transported to the
Laboratoire Arago’s animal facility. Shrews were housed in cages
with 3 cm soil substratum, and provided with a hollow cylindrical
piece of cork for shelter and moss for nesting material. All
experimental procedures were approved by the Centre National
de la Recherche Scientifique (CNRS).
Melatonin Implants
The pharmacological dose of melatonin continuously delivered
to individuals was supplied using implants adapted to the average
body weight of shrews (10 g) [51]. They consisted of Silastic tubes
(Dow Corning, medical grade, external diameter 1.96 mm,
interior diameter 1.47 mm, length 5 mm) filled with 5 mg
melatonin (N-acetyl 1-5-methoxytryptamine; Sigma Chemicals,
St Louis, MO), and plugged with medical silicone (type A; Dow
Corning, Midland, MI). One tube per animal was implanted
subcutaneously in the dorsal region near the clavicle. Empty
implants were prepared following the same protocol but as a
separate set in order to avoid melatonin contamination.
Measurements of plasma and pineal melatonin content
Plasma and pineal levels of melatonin were measured for the first
generation of wild-trapped shrews ranging from 1 to 32 mo.
Individuals were randomly assigned to a treatment (implanted with
melatonin or not implanted), an age, and a light phase group.
Animals were euthanized either during the night or during the day (4
pm or 11 pm UT respectively). A total of 57 control shrews born in
captivity were sampled from 1 to 32 mo, both for plasma and pineal
gland assays. Plasma levels of melatonin were also measured in 4
implanted animals, 1 week and 3 months (2 each) after implantation.
Pineal glands were flash frozen in liquid nitrogen immediately after
collection, and stored at 280uC. In order to extract melatonin, they
were defrosted and ground in 200 mL methanol using a sonicator
(5 sec, Tmax=40uC). The mix was completed with 300 mL
methanol and homogenized by vortexing for 2 min. Samples were
centrifuged for 2 min at 3,000 rpm at room temperature. The
supernatant was then transferred to a new collection tube, and placed
under high vacuum (1610
23 Torr) until the liquid was completely
removed. Samples were suspended in 50 mL ultra pure water, and
stored at 220uC until the assay was performed. Blood was collected
in heparin tubes and kept on ice for 4 hours. Samples were
centrifuged for 10 min at 2,500 rpm at room temperature to extract
the plasma and then stored at 280uCu n t i lu s e .
An indirect measurement was also performed in order to more
accurately estimate the dose delivered by the implant over time.
Six melatonin implants were individually immersed in 1 mL
physiological buffer maintained at 37uC (shrews’ body tempera-
ture), and renewed every day for 130 days. The melatonin content
of the liquid was measured from day 1 to 7, 10 to 22, 30 to 48, and
finally at days 59, 78, and 130.
Physiological buffer, plasma and pineal melatonin levels were
measured using an enzyme-linked immunosorbent (ELISA) kit
after purification according to the kit protocol (IBL, Hambourg). A
nonparametric two-way analysis of variance (Scheirer-Ray-Hare
test, [52]) was run using the R 2.8.1 package to assess the effect of
light, age and the light*age interaction on pineal and plasma
melatonin production. Mann Whitney U tests were then
performed for pairwise comparison of means.
Monitoring of shrews’ activity rhythm
Juvenile (one to 2 mo) wild shrews were housed separately from
mating pairs. By the age of nine to 10 months, they were
transferred from a 12:12 light:dark (LD) cycle to a natural one.
The ambient temperature was 2262uC. They were housed in
50630670 cm individual glass vivaria where the floor was covered
with soil; in the vivaria the animals were provided with an intricate
light-proof plaster structure for shelter. Shrews were supplied ad
libitum with water and fresh food consisting of crickets (Acheta
domesticus) and mealworms (Tenebrio molitor). Water and food were
supplied outside the nest and at a different time each day. The
acclimation period to the daily activity monitoring system lasted at
least 60 days before the beginning of the experiment. By the age of
12 months, male and female shrews were randomly assigned to
three treatment groups consisting of animals that received a
subcutaneous melatonin implant (seven shrews) whereas control
shrews received either an empty implant or no implant at all (four
animals total). The implants were renewed two times every five
months. The sample size corresponded to 11, 9, and 6 shrews at,
Melatonin Delays Senescence
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alive until 30 mo. Mortality was not significantly affected by the
melatonin treatment (Mann-Whitney U test, adjusted Z=21.15,
P=0.250). Recording the animal entrances and exits of the nest
was performed using two infrared emitting diodes coupled to
phototransistor sensors placed at the entrance of each plaster nest.
The sensors were connected to a computer via a multiplexer. The
data were acquired simultaneously and continuously (24 h a day, 7
days a week) for each individual of the three treatments for up to
535 days, and managed by generating a MySQL database.
Analysis of rhythmic activity data
We used the khi-2 periodogram to define the activity rhythm
periodicity. We looked for periods in the time series between 14
and 34 h. Ten day-long subseries were analyzed applying the
moving window principle: successive subseries overlapping by one
day were built and analyzed (sub-series 1: day 1 to day 10,
subseries 2: from day 2 to day 11, etc [53]. This technique allowed
us to follow the evolution of the periodicities present in the series.
The significance of the 24 h period was displayed as a ‘‘24 h
period degradation index’’. This index was estimated by first











xk{ x x ðÞ
2
where p=period (24), n=row number (10),  x xi =mean number of
exits for column i (10 values), xk=number of exits (for k=1 to
np=240; [53] demonstrated that q(p) behaves as a khi-2 variable
with p21 degrees of freedom. A critical value q1{a~x2
p{1 1{a ðÞ
was therefore calculated where 1/p corresponds to the ‘‘24 h-
period significance index’’.
An amplitude degradation index I(d) was also built in order to
track the evolution of the amplitude. I(d) was obtained by
calculating the mean activity profile on the first 30 days of the
series and then by measuring the difference between this mean
profile and each successive daily profile, according to the formula:
I d ðÞ ~
P24
h~1 FR h ðÞ {Fd h ðÞ jj
24
, where d=day, h=hour, FR=mean
exit activity on the 30 first days for hour h, Fd (h) =exit activity at d
day and h hour.
Activity profiles obtained for shrews that received an empty
implant or no implant were pooled because the data obtained
from the two groups did not differ significantly.
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